Blood transfusion and non-Hodgkin lymphoma: Lack of association

Annals of Internal Medicine

Volumn 127, Issue 5, 1997, Pages 365-371

  Adami, Johanna ^a   Nyrén, Olof ^a   Bergström, Reinhold ^a   Ekbom, Anders ^a   McLaughlin, Joseph K ^b   Högman, Claes ^c   Fraumeni Jr , Joseph F ^d   Glimelius, Bengt ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RISK ASSESSMENT; SWEDEN;

EID: 0030854891     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-127-5-199709010-00004     Document Type: Article

References (40)

1. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361-92.
2. Carli PM, Boutron MC, Maynadié M, Bailly F, Caillot D, Peterella T. Increase in the incidence of non-Hodgkin's lymphomas: evidence for a recent sharp increase in France independent of AIDS. Br J Cancer. 1994;70:713-5.
3. Devesa SS, Fears T. Non-Hodgkin's lymphoma time trends: United States and international data. Cancer Res. 1992:52(19 Suppl):5432S-40S.
4. Cartwright RA. Changes in the descriptive epidemiology of non-Hodgkin's lymphoma in Great Britain? Cancer Res. 1992:52(19 Suppl):5441S-2S.
5. Martinsson U, Glimelius B, Sundström C. Lymphoma incidence in a Swedish county during 1969-1987. Acta Oncol. 1992;31:275-82.
6. Hjalgrim H, Frisch M, Begtrup K, Melbye M. Recent increase in the incidence of non-Hodgkin's lymphoma among young men and women in Denmark. Br J Cancer. 1996;73:951-4.
7. Hakulinen T, Andersen A, Malker B, Pukkala E, Schou G, Tulinius H. Trends in cancer incidence in the Nordic countries. A collaborative study of the five Nordic Cancer Registries. Acta Pathol Microbiol Immunol Scand Suppl. 1986;288:1-151.
8. Zheng T, Mayne ST, Boyle P, Holdford TR, Liu WL, Flannery J. Epidemiology of non-Hodgkin lymphoma in Connecticut. 1935-1988. Cancer. 1992;70:840-9.
9. Mueller BU, Pizzo PA. Cancer in children with primary or secondary immunodeficiencies. J Pediatr. 1995;126:1-10.
10. Biggar RJ, Rabkin CS. The epidemiology of acquired immunodeficiency syndrome-related lymphomas. Curr Opin Oncol. 1992;4:883-93.
11. Rabkin CS, Biggar RJ, Horm JW. Increasing incidence of cancers associated with the human immunodeficiency virus epidemic. Int J Cancer. 1991;47: 692-6.
12. Filipovich AH, Shapiro R, Robinson L, Mertens A, Frizzera G. Lympho-proliferative disorders associated with immunodeficiency. In: Magrath IT, ed. The Non-Hodgkin's Lymphomas. London: E. Arnold; 1990:135-54.
13. Kinlen LJ. Immunosuppressive therapy and cancer. Cancer Surv. 1982;1:565-83.
14. Opelz G, Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet. 1993;342:1514-6.
15. Penn I. Secondary neoplasms as a consequence of transplantation and cancer therapy. Cancer Detect Prev. 1988;12:39-57.
16. Brunson ME, Alexander JW. Mechanisms of transfusion-induced immunosuppression. Transfusion. 1990;30:651-8.
17. Triulzi DJ, Heal JM, Blumberg N. Transfusion-induced immunomodulation and its clinical consequences. In: Nance ST, ed. Transfusion Medicine in the 1990's. Arlington, VA: American Assoc Blood Banks; 1990:1-33.
18. Blumberg N, Heal JM. Transfusion-associated immunomodulation. In: Anderson KC, Ness PM, eds. Scientific Basis of Transfusion Medicine: Implications for Clinical Practice. Philadelphia: WB Saunders; 1994:580-97.
19. Tartter PI. Blood transfusion and infectious complications following colorectal cancer surgery. Br J Surg. 1988;75:789-92.
20. Tartter Pl. Blood transfusion and postoperative infections. Transfusion. 1989; 29:456-9.
21. Mezrow CK, Bergstein I, Tartter PI. Postoperative infections following autologous and homologous blood transfusions. Transfusion. 1992;32:27-30.
22. Triulzi DJ, Vanek K, Ryan DH, Blumberg N. A clinical and immunologic study of blood transfusion and postoperative bacterial infection in spinal surgery. Transfusion. 1992;32:517-24.
23. Tartter PI. Transfusion-induced immunosuppression and perioperative infections. Beitr Infusionsther. 1993;31:52-63.
24. Blomberg J, Möller T, Olsson H, Anderson H, Jonsson M. Cancer morbidity in blood recipients - results of a cohort study. Eur J Cancer. 1993; 29A:2101-5.
25. Cerhan JR, Wallace RB, Folsom AR, Potter JD, Munger RG, Prineas RJ. Transfusion history and cancer risk in older women. Ann Intern Med. 1993; 119:8-15.
26. Memon A, Doll R. A Search for unknown blood-borne oncogenic viruses. Int J Cancer. 1994;58:366-8.
27. Brandt, L, Brandt J, Olsson H, Anderson H, Möller T. Blood transfusion as a risk factor for non-Hodgkin lymphoma. Br J Cancer. 1996;73:1148-51.
28. Nyrén O, McLaughlin JK, Gridley G, Ekbom A, Johnell O, Fraumeni JF Jr, et al. Cancer risk after hip replacement with metal implants: a population-based cohort study in Sweden. J Natl Cancer Inst. 1995;87:28-33.
29. Hansson LE, Nyrén O, Hsing AW, Bergstrom R, Josefsson S, Chow WH, et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med. 1996;335:242-9.
30. Naessén T, Parker R, Persson I, Zack M, Adami HO. Time trends in incidence rates of first hip fracture in the Uppsala Health Care Region, Sweden, 1965-1983. Am J Epidemiol. 1989;130:289-99.
31. Nilsson AC, Spetz CL, Carsjö K, Nightingale R, Smedby B. Slutenvårdsregistrets tillförlitlighet. Diagnosuppgifterna är bättre än sitt rykte [Reliability of the hospital registry. The diagnostic data are better than their reputation.] Läkartidningen. 1994;91:598, 603-5.
32. Swedish Cancer Registry. Cancer Incidence in Sweden. Stockholm: National Board of Health; 1996.
33. Hogman C, Ramgren O. Computer system for blood transfusion service. Transfusion. 1970;10:121-32.
34. Davis W, Breslow NE, Day NE. Statistical Methods in Cancer Research, v 1. Lyon: International Agency for Research on Cancer; 1980.
35. Pioltelli P, Zehender G, Monti G, Monteverde A, Galli M. HCV and non-Hodgkin lymphoma [Letter]. Lancet. 1996;347:624-5.
36. Ferri C, Carraciolo F, Zignego AL, La Civita L, Monti M, Longombardo G, et al. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol. 1994;88:392-4.
37. Izumi T, Sasaki R, Miura Y, Okamoto H. Primary hepatosplenic lymphoma: association with hepatitis C virus infection. Blood. 1996;87:5380-1.
38. Wacholder S, McLaughlin JK, Silverman DT, Mandel JS. Selection of controls in case-control studies. I. Principles. Am J Epidemiol. 1992;135: 1019-28.
39. Wacholder S, Silverman DT, McLaughlin JK, Mandel JS. Selection of controls in case-control studies. II. Types of controls. Am J Epidemiol. 1992; 135:1029-41.
40. Wacholder S, Silverman DT, McLaughlin JK, Mandel JS. Selection of controls in case-control studies. III. Design options. Am J Epidemiol. 1992; 135:1042-50.